Search results
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up
Zacks via Yahoo Finance· 1 year agoPharming Group (PHAR) obtains FDA approval for leniolisib for the treatment of a rare pediatric...
Pharming's Leniolisib Goes Under Priority FDA Review For Rare Immune System Disorder
Benzinga via Yahoo Finance· 2 years agoThe FDA has accepted Pharming Group NV's (NASDAQ: PHAR) marketing application seeking approval for...
FDA Approves Pharming's Immune Disorder Drug, As First APDS Therapy
Benzinga via Yahoo Finance· 1 year agoThe FDA approved Pharming Group N.V.'s (NASDAQ: PHAR) Joenja (leniolisib) for activated...
Pharming Highlights Interim Data From Rare Immune Deficiency Study
Benzinga via Yahoo Finance· 1 year agoPharming Group N.V. (NASDAQ: PHAR) announced data from an interim analysis of its open-label...
US FDA approves Pharming's immune disorder drug
Reuters via Yahoo News· 1 year ago(Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Pharming Group's drug to treat a rare genetic disorder that leads to a weakened...
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 7 days agoPharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than...